- Research category
- Growth Hormone
- Format
- Lyophilized peptide material
- Purity spec
- Greater than 99%
- Availability
- Approved accounts
- Documentation
- COA coming soon
Certificate of Analysis coming soon
Growth Hormone
Tesamorelin / Ipamorelin
Blend of Tesamorelin, a GHRH analog with FDA-approved Egrifta history for HIV lipodystrophy, and Ipamorelin, positioned for visceral-fat and GH optimization research. Mechanism: Two-key GH mechanism: Tesamorelin triggers GH production with specific visceral fat reduction data; Ipamorelin triggers GH release.
- Availability
- Wholesale Access Only
Tesamorelin / Ipamorelin · Research use only
Research context
Visceral fat reduction; GH optimization with body composition focus; truncal fat accumulation.
Material information
- Grade
- Research Use Only (RUO)
- Format
- Lyophilized peptide material
- Purity
- Greater than 99%
- Appearance
- Lyophilized powder
Documentation
Batch-specific documentation may be available for approved account review. View documentation standards.
Regulatory status
For laboratory research use only. Not for human consumption, diagnosis, treatment, cure, or prevention of disease.
Restrictions
Research use only
This material is offered for research use only. Not for human or animal use. Not intended for clinical, diagnostic, therapeutic, veterinary, or personal use. PeptaPharma does not provide dosing, administration, or treatment guidance.
Related materials
Synthesized & tested in the United States.
PeptaPharma materials are produced and analytically tested in U.S. facilities. Batch-level documentation and Certificates of Analysis accompany each lot for approved-account review.